首页> 外国专利> COMPOSITION FOR EVALUATING OR PREDICTING PATIENTS THERAPEUTIC RESPONSE TO METHORMIN

COMPOSITION FOR EVALUATING OR PREDICTING PATIENTS THERAPEUTIC RESPONSE TO METHORMIN

机译：评估或预测患者对甲基溴的治疗反应的组合物

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a biomarker for evaluating or predicting response of a patient to metformin, and use thereof. The present invention relates to a composition and a kit for evaluating or predicting therapeutic response of a patient to metformin, comprising an agent capable of detecting one or more microorganisms selected from the group consisting of Blautia, Shigella and Clostridium. And, the present invention relates to a method for detecting one or more microorganisms selected from the group consisting of Blautia, Shigella and Clostridium from the sample of a patient, so as to provide information required for evaluating or predicting response to metformin.

机译：本发明涉及用于评估或预测患者对二甲双胍的反应的生物标志物及其用途。本发明涉及用于评估或预测患者对二甲双胍的治疗反应的组合物和试剂盒，其包含能够检测一种或多种选自 Blautia，志贺氏菌和的微生物的试剂。 I>梭菌属。并且，本发明涉及一种从患者样品中检测选自蓝藻，志贺氏菌和梭状芽孢杆菌的一种或多种微生物的方法，以便提供评估或预测对二甲双胍反应所需的信息。 展开▼

著录项

公开/公告号US2016160267A1

专利类型

公开/公告日2016-06-09

原文格式PDF

申请/专利权人 SNU R&DB FOUNDATION;
展开▼

申请/专利号US201314905327

发明设计人 GWANG PYO KO;HEE TAE LEE;
展开▼

申请日2013-07-19

分类号C12Q1/68;A61K31/155;

国家 US

入库时间 2022-08-21 14:33:40

相似文献

专利

外文文献

中文文献

1. 预测乳腺癌患者对吡咯替尼治疗反应性的生物标记物 [P] . 中国专利： CN106119398B . 2019.10.25

2. 预测乳腺癌患者对吡咯替尼治疗反应性的生物标记物 [P] . 中国专利： CN106119398A . 2016-11-16

3. anti-erbb3 therapeutic agent for use in tumor therapy, methods for predicting tumor responsiveness of an anti-erbb3 therapeutic agent, for selecting anti-erbb3 therapy for a patient, for predicting cell response to treatment with a therapeutic agent , to identify a biomarker, and to prevent administration of an anti-erbb3 cancer drug, and kit to predict cell response to treatment with a therapeutic agent [P] . BRPI0917871A2 . 2017-06-20

机译：用于肿瘤治疗的抗erbb3治疗剂，预测抗erbb3治疗剂的肿瘤反应性，为患者选择抗erbb3治疗剂，预测对治疗剂治疗的细胞反应以鉴定生物标志物的方法，和预防抗erbb3癌症药物的给药，以及用于预测细胞对治疗剂治疗反应的试剂盒

4. COMPOSITION FOR EVALUATING OR PREDICTING PATIENT'S THERAPEUTIC RESPONSE TO METFORMIN [P] . 世界知识产权组织专利： WO2015008884A1 . 2015-01-22

机译：评估或预测患者对二甲双胍治疗反应的组合

5. method for determining if ec145 is indicated for the treatment of a patient with an ovarian tumor or a lung tumor; method for predicting a response from an ovarian tumor or a lung tumor of a patient to ec145 therapy; method of treating platinum-resistant ovarian cancer in a patient in need; use of ec145 in combination with pegylated liposomal doxorubicin; use of ec145 for the manufacture of a medicament; method for obtaining a clinical benefit compared to treatment with a therapeutic amount of pegylated liposomal doxorubicin in the treatment of platinum-resistant ovarian cancer in a patient in need thereof; method for selecting a patient for treatment; pharmaceutical composition; dosage unit, method for determining if a patient with a tumor has functionally active folate receptors present in the patient's tumor; method of treating a folate receptor expressing epithelial tumor in a patient in need thereof; and; method for obtaining a clinical benefit in the treatment of a folate recepto [P] . BR112012002064A2 . 2017-05-09

机译：确定ec145是否适合治疗卵巢肿瘤或肺肿瘤患者的方法;预测患者的卵巢肿瘤或肺肿瘤对ec145治疗的反应的方法;在有需要的患者中治疗铂耐药的卵巢癌的方法; ec145与聚乙二醇化阿霉素组合使用; ec145在制造药物中的用途;与治疗量的聚乙二醇化脂质体阿霉素治疗相比获得临床益处的方法，在有需要的患者中治疗铂耐药性卵巢癌;选择患者进行治疗的方法;药物组合物;剂量单位，用于确定患有肿瘤的患者是否具有存在于患者肿瘤中的功能活性叶酸受体的方法;在有需要的患者中治疗表达叶酸受体的上皮肿瘤的方法;和;治疗叶酸受体的临床方法

1. Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients [J] . Wang Xu, Ma Kewei, Wang Yizhuo, Archives of medical research . 2016,第6期

2. Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C. [J] . Reau N, Satoskar R, Te H, The American Journal of Gastroenterology . 2011,第3期

3. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response [J] . Feifei Zhang, Wenjie Wang, Yuan Long, Chinese journal of cancer . 2018,第1期

4. Connecting clusters of patient to drug responses of cell lines to suggest personalized therapeutics for breast cancer [C] . Gordonov Simon, Maayan Avi 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops. . 2012

5. Evaluating response to treatment and predicting outcome in patients with metastatic colorectal carcinoma using statistical learning theory . [D] . Margolis, Daniel Eli. 2010

6. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response [O] . Feifei Zhang, Wenjie Wang, Yuan Long, 2018

7. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

8. Evaluation of a New Marker of the Ovarian Tumor Vasculature for Predicting Response to Treatment and as a Therapeutic Target. [R] . Radu, A. 2012

1. Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients [J] . Min-Woo Chung ,Moon-Ju Kim ,Eun Jeong Won . 世界胃肠病学杂志:英文版 . 2021,第42期

2. Evaluation of the Therapeutic Response and Improvement in the Quality of Life of the Patient with Darier Disease to Acitretin through an Analogy between Close Relatives [J] . Thiago Sande Miguel ,Mateus de Oliveira Reis ,Bruno Fonseca dos Santos . 生物科学与医学（英文） . 2017,第8期

3. Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization with Drug-Eluting Beads [J] . Natália Sousa Freitas Queiroz ,Luciana Kikuchi ,Regis Otaviano Franca Bezerra . 癌症治疗（英文） . 2015,第13期

4. The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Patients with Chronic Hepatitis C Receiving a Personalized Treatment Program [J] . Ming-hui Li ,Cai-qin Mu ,Lei-ping Hu . 国际感染杂志（电子版） . 2013,第002期

5. The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Patients with Chronic Hepatitis C Receiving a Personalized Treatment Program [J] . 无 . 国际感染杂志（电子版） . 2013,第002期

6. 2，6-二甲基苯酚溴化制备4-溴-2，6-二甲基苯酚的研究 [C] . 刘寿卿 ,廖鸿文 ,李建武 . 第五届全国精细化学品化学学术讨论会 . 1999

7. 外周血foxp3基因特异性甲基化区域甲基化水平检测：可作为自身免疫病与慢性感染患者病情评估潜在的标记物 [A] . Owen Ngalamika(欧文) . 2013